Last edition
News about "Penumbra"
Boston Scientific will acquire Penumbra in a USD 14.5 billion cash and stock deal to expand its vascular and neurovascular portfolio, strengthening its position in thrombectomy, stroke, and cardiovascular disease treatment markets.
Penumbra | 17/01/2026 | By News Bureau | 227
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members